NCCN Breast Cancer Version 4.2026: Metastatic Treatment Moves Further Toward Biomarker-Driven Sequencing

Ask HN: What is the latest on treatment of Metastatic Breast Cancer?

I was reading this recently shared post on the promise of CAR-T therapy for cancer[1]. However, it seems that it may not be universally appl

Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer

Conditions : Breast Cancer (Triple Negative Breast Cancer (TNBC)) Interventions : Other: Non interventional study Sponsors : Assistance Publ

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy

Methylation-based ctDNA monitoring in 57 patients closely reflects outcomes in ER+, HER2- metastatic breast cancer during CDK4/6 inhibitor t

<![CDATA[20 On the Upswing: A Retrospective Cohort Study Evaluating Neoadjuvant Chemotherapy Response in Metaplastic Breast Cancer Patients]]>

<![CDATA[Oncology PulsePoint: ASCO Updates Targeted Therapy for Stage IV NSCLC]]>

<![CDATA[19 Targeted Axillary Dissection—Does the Biopsy-Proven Node Need to Be Localized? A Retrospective Review of Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy]]>